CAS No. |
1629760-28-6 |
|---|---|
英文名称 |
- |
别名 |
Ladiratuzumab;Research Grade Ladiratuzumab (DHG52901);Research Grade Ladiratuzumab;Ladiratuzumab (anti-SLC39A6);hLIV22 |
用途 |
Ladiratuzumab is used in the research of breast cancer; it can be conjugated with the microtubule-disrupting agent MMAE to form the antibody-drug conjugate (ADC) SGN-LIV1A. |
|
|
评论 |
|---|